29 October 2024
29 October 2024
The transaction will be finalised in the fourth quarter of 2024.
China's virtual monopoly on the supply of many APIs could be dangerous for the security of medicine supply to Western countries.
As the retail drug pharmacy space undergoes significant change, new formats and designs that centre on the consumer are emerging.
As of August 2023, a total of 68 drugs were introduced into the South Korean reimbursement list with risk-sharing agreements (RSAs).
Ahead of the upcoming DSCSA November deadline, pharma companies reimagine track-and-trace to tackle the US counterfeit drug landscape.
At the Outsourcing in Clinical Trials Conference, government personnel advised attendees on the transport of biologics across borders.
The EC’s decision is supported by results from the MANDARA Phase III trial.
UPFs have become a staple of many diets worldwide, but overconsumption is contributing to an obesity epidemic in India.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
